Barringer D. Marshall

1.2k total citations
31 papers, 942 citations indexed

About

Barringer D. Marshall is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Barringer D. Marshall has authored 31 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 8 papers in Cognitive Neuroscience and 7 papers in Pharmacology. Recurrent topics in Barringer D. Marshall's work include Schizophrenia research and treatment (18 papers), Treatment of Major Depression (7 papers) and Mental Health and Psychiatry (7 papers). Barringer D. Marshall is often cited by papers focused on Schizophrenia research and treatment (18 papers), Treatment of Major Depression (7 papers) and Mental Health and Psychiatry (7 papers). Barringer D. Marshall collaborates with scholars based in United States, Canada and United Kingdom. Barringer D. Marshall's co-authors include William C. Wirshing, Robert S. Kern, Jim Mintz, Susan R. McGurk, M F Green, Stephen R. Marder, S.R. Marder, David Ames, Donna A. Wirshing and Michael F. Green and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Bulletin.

In The Last Decade

Barringer D. Marshall

31 papers receiving 880 citations

Peers

Barringer D. Marshall

PMH

PHILO

CMN

T. Kolakowska United Kingdom

R. W. Buchanan United States

Steven Zalcman United States

Stephen M. Erhart United States

Luchezar Hranov Israel

Seema Quraishi United Kingdom

Evelyn Howanitz United States

A. Labelle Canada

René S. Kahn Netherlands

Jonathan S.E. Hellewell United Kingdom

T. Kolakowska United Kingdom

Barringer D. Marshall

905 ×1.2

PMH

166 ×0.7

191 ×0.8

175 ×0.8

PHILO

172 ×1.3

CMN

Citations per year, relative to Barringer D. Marshall Barringer D. Marshall (= 1×) peers T. Kolakowska

Countries citing papers authored by Barringer D. Marshall

Since Specialization

Citations

This map shows the geographic impact of Barringer D. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barringer D. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barringer D. Marshall more than expected).

Fields of papers citing papers by Barringer D. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barringer D. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barringer D. Marshall. The network helps show where Barringer D. Marshall may publish in the future.

Co-authorship network of co-authors of Barringer D. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Barringer D. Marshall. A scholar is included among the top collaborators of Barringer D. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barringer D. Marshall. Barringer D. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marshall, Barringer D.. (2020). Assessing Patient Fall Risk on Psychiatric Units: A Comparison of Three Fall Risk Scales. 2(4). 1 indexed citations

Liberman, Robert Paul, et al.. (2002). Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia. Comprehensive Psychiatry. 43(6). 469–473. 12 indexed citations

Wirshing, Donna A., Barringer D. Marshall, M F Green, et al.. (1999). Risperidone in Treatment-Refractory Schizophrenia. American Journal of Psychiatry. 156(9). 1374–1379. 115 indexed citations

Kern, Robert S., M. F. Green, Barringer D. Marshall, et al.. (1999). Risperidone versus Haloperidol on Secondary Memory: Can Newer Medications Aid Learning?. Schizophrenia Bulletin. 25(2). 223–232. 80 indexed citations

Kern, Robert S., Michael F. Green, Barringer D. Marshall, et al.. (1998). Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients. Biological Psychiatry. 44(8). 726–732. 74 indexed citations

Kee, Kimmy S., Robert S. Kern, Barringer D. Marshall, & Michael F. Green. (1998). Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophrenia Research. 31(2-3). 159–165. 87 indexed citations

Green, Michael F., Barringer D. Marshall, William C. Wirshing, et al.. (1997). Risperidone's effects on verbal working memory. Schizophrenia Research. 24(1-2). 214–214. 3 indexed citations

Aravagiri, Manickam, Stephen R. Marder, Theodore Van Putten, & Barringer D. Marshall. (1994). Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol. Journal of Chromatography B Biomedical Sciences and Applications. 656(2). 373–381. 23 indexed citations

Midha, K.K., John W. Hubbard, Stephen R. Marder, Barringer D. Marshall, & Theodore Van Putten. (1994). Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.. PubMed. 19(4). 254–64. 19 indexed citations

10.

Putten, Theodore Van, Barringer D. Marshall, Robert Paul Liberman, et al.. (1993). Systematic dosage reduction in treatment-resistant schizophrenic patients.. PubMed. 29(2). 315–20. 17 indexed citations

11.

Kuehnel, Timothy G., et al.. (1992). Optimal drug and behavior therapy for treatment‐refractory institutionalized schizophrenics. New Directions for Mental Health Services. 1992(53). 67–78. 2 indexed citations

12.

Hubbard, John W., et al.. (1992). Pharmacokinetics of Fenfluramine and Neuroleptics in the Treatment of Refractory Schizophrenia. Clinical Drug Investigation. 4(2). 99–111. 1 indexed citations

13.

Marshall, Barringer D., et al.. (1991). Weight loss in the Prader-Willi Syndrome: Treatment and long-term follow-up. Journal of Developmental and Physical Disabilities. 3(1). 47–57. 4 indexed citations

14.

Glynn, Shirley M., et al.. (1990). Successful behavioral treatment of polydipsia in a schizophrenic patient. Journal of Behavior Therapy and Experimental Psychiatry. 21(1). 53–61. 8 indexed citations

15.

Marshall, Barringer D., Shirley M. Glynn, Kamal K. Midha, et al.. (1989). Adverse Effects of Fenfluramine in Treatment Refractory Schizophrenia. Journal of Clinical Psychopharmacology. 9(2). 110–115. 19 indexed citations

16.

Glynn, Shirley M., et al.. (1989). Compliance With Less Restrictive Aggression-Control Procedures. Psychiatric Services. 40(1). 82–84. 11 indexed citations

17.

Liberman, Robert Paul, et al.. (1984). Long-Term Follow-up of the Effects of Behavior Therapy. Psychiatric Services. 35(3). 277–279. 11 indexed citations

18.

Marshall, Barringer D., et al.. (1983). Maintaining nursing staff performance on an intensive behavior therapy unit. 3(2-3). 193–204. 6 indexed citations

19.

Marshall, Barringer D., et al.. (1979). The Problem Oriented Medical Record: Its Adaption to a Behavior Modification Unit. Scandinavian Journal of Behaviour Therapy. 8(2). 57–67. 3 indexed citations

20.

Curtin, James A. & Barringer D. Marshall. (1962). Use of antibiotics in cancer and leukemia. Journal of Chronic Diseases. 15(7). 713–718. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact